The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Genetic Test Maker 23andMe Launches Drug R&D Effort

March 12, 2015 8:11 am | by MATTHEW PERRONE, AP Health Writer | News | Comments

Google-backed genetic testing company 23andMe is launching its own drug development unit, betting that it can translate its database of customer DNA information into novel medicines.


Valeant Faces Another Takeover Battle as Endo Submits Higher Bid for Salix

March 12, 2015 8:07 am | by Ross Marowits, The Canadian Press | News | Comments

Valeant Pharmaceuticals faced another takeover fight Wednesday after Endo International submitted a higher bid for drugmaker Salix Pharmaceuticals.


Acadia Shares Slide, Drug Delay Announced

March 12, 2015 8:01 am | by The Associated Press | News | Comments

Shares of Acadia Pharmaceuticals shed nearly a quarter of their value in premarket trading Thursday, a day after the drug developer announced the sudden retirement of its long-time CEO and said it will delay the regulatory submission for its most advanced product.


Analyst: Decline in Cases Curbs Ebola Drug Clinical Trials

March 11, 2015 4:08 pm | by Andy Szal, Digital Reporter | News | Comments

The sharp decline in Ebola cases since the peak of the virus’ largest-ever outbreak could hamper efforts to treat the disease in the future.


Study: Tetanus Shot May Aid Treatment of Deadly Brain Cancer

March 11, 2015 3:51 pm | by MALCOLM RITTER, AP Science Writer | News | Comments

A dose of tetanus vaccine let patients live longer when added to an experimental treatment for the most common and deadly kind of brain tumor, researchers report.


Endo Tops Valeant's Offer for Salix

March 11, 2015 3:31 pm | by The Associated Press | News | Comments

Endo International is trying to lure fellow drugmaker Salix Pharmaceuticals with an offer Endo says is worth 11 percent more than the $10 billion Salix has agreed to accept from serial acquirer Valeant Pharmaceuticals.



March 11, 2015 11:46 am | by Festo Corporation | Festo Corporation | Product Releases | Comments

The VSNC series replaces two existing products for NAMUR valve applications. With multiple coil options, including Class I Division 1(FM) or intrinsic safety, the VSNC is an excellent fit for ordinary environments and hazardous locations alike.

More Prosecutors Join NY Herbal Supplement Inquiry

March 11, 2015 8:35 am | by MARY ESCH, Associated Press | News | Comments

Prosecutors from Connecticut, Indiana and Puerto Rico have joined New York's attorney general in an investigation of the herbal supplement industry, saying they're building on the long track record of state attorneys general upholding the rights of consumers.


WHO Creates Independent Panel to Assess its Ebola Response

March 11, 2015 8:33 am | News | Comments

The World Health Organization says it has created a panel of independent experts to assess its response to the biggest-ever Ebola outbreak in history.


Paul Joins Democrats in Bid to Boost Medical Marijuana

March 11, 2015 8:31 am | by MATTHEW DALY, Associated Press | News | Comments

Two Democratic senators and a possible Republican presidential candidate joined forces Tuesday to push a bill to remove federal prohibitions on medical marijuana in 23 states where it's already legal.


Actavis and Allergan Shareholders Approve Acquisition

March 11, 2015 8:26 am | News | Comments

Actavis and Allergan, Inc. announced that, at shareholder meetings held yesterday, all proposals related to Actavis’ planned acquisition of Allergan were approved by both Actavis’ and Allergan’s shareholders.


McNeil Consumer Healthcare Pleads Guilty to Metal Particles in Kids' Tylenol

March 11, 2015 8:23 am | by MICHAEL RUBINKAM, Associated Press; MARYCLAIRE DALE, Associated Press | News | Comments

McNeil Consumer Healthcare, of Fort Washington, Pennsylvania, acknowledged failing to take corrective action after discovering the adulterated bottles of Infants' and Children's Tylenol and Children's Motrin. The company agreed to pay $25 million to resolve the case.


Pernix to Acquire Zohydro® ER Franchise from Zogenix

March 11, 2015 8:14 am | News | Comments

Pernix Ireland Limited has signed a definitive agreement to acquire the Zohydro ER franchise from Zogenix, Inc. The acquisition includes three extended release hydrocodone products, including an abuse-deterrent pipeline and all related intellectual property.


Report: Prospective Pain Treatments Could Be 'Game-Changing'

March 11, 2015 8:06 am | by Andy Szal, Digital Reporter | News | Comments

Healthcare industry analysts expect promising new pain therapy medications to hit the market in the near future despite a decline in recent pharmaceutical patent applications.


Legislation Targets Detergent Packets Following Rash of Child Poisonings

March 10, 2015 2:42 pm | by Andy Szal, Digital Reporter | News | Comments

Democratic members of Congress hope to make substantial changes to single-load laundry detergent packets amid rising concerns about accidental ingestion by children.  



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.